Piukovics K, Terhes G, Gurbity-Pálfi T, Bereczki Á, Rárosi F, Deák J, et al. Cytomegalovirus infection in patients with haematological diseases and after autologous stem cell transplantation as consolidation: a single-centre study. Ann Hematol. 2017;96:125–31. https://doi.org/10.1007/s00277-016-2831-7.
CAS Article PubMed Google Scholar
Ljungman P, Brand R, Einsele H, Frassoni F, Niederwieser D, Cordonnier C. Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis. Blood. 2003;102(13):4255–60. https://doi.org/10.1182/blood-2002-10-3263.
CAS Article PubMed Google Scholar
Ljungman P, Brand R. Factors influencing cytomegalovirus seropositivity in stem cell transplant patients and donors. Haematologica. 2007;92:1139–42. https://doi.org/10.3324/haematol.11061.
Lachmann R, Loenenbach A, Waterboer T, Brenner N, Pawlita M, Michel A, et al. Cytomegalovirus (CMV) seroprevalence in the adult population of Germany. PLoS ONE. 2018;13(7):e0200267. https://doi.org/10.1371/journal.pone.0200267.
CAS Article PubMed PubMed Central Google Scholar
Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20:202–13. https://doi.org/10.1002/rmv.655.
Marshall GS, Rabalais GP, Stewart JA, Dobbins JG. Cytomegalovirus seroprevalence in women bearing children in Jefferson County. Kentucky Am J Med Sci. 1993;305:292–6. https://doi.org/10.1097/00000441-199305000-00005.
CAS Article PubMed Google Scholar
Cheeran MC-J, Lokensgard JR, Schleiss MR. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev. 2009;22(1):99–126. https://doi.org/10.1128/CMR.00023-08.
CAS Article PubMed PubMed Central Google Scholar
Michaelis M, Doerr HW, Cinatl J. The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia. 2009;11(1):1–9. https://doi.org/10.1593/neo.81178.
CAS Article PubMed PubMed Central Google Scholar
Cinatl J Jr, Cinatl J, Vogel JU, Rabenau H, Kornhuber B, Doerr HW. Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology. 1996;39(4):259–69. https://doi.org/10.1159/000150527.
Cinatl J, Vogel JU, Cinatl J, et al. Long-term productive human cytomegalovirus infection of a human neuroblastoma cell line. Int J Cancer. 1996;65:90–6. https://doi.org/10.1002/(SICI)1097-0215(19960103)65:1%3c90:AID-IJC16%3e3.0.CO;2-M.
Nelson JA, Fleckenstein B, Jahn G, et al. Structure of the transforming region of human cytomegalovirus AD169. J Virol. 1984;49:109–15. https://doi.org/10.1128/JVI.49.1.109-115.1984.
CAS Article PubMed PubMed Central Google Scholar
Boldogh I, Huang ES, Rady P, et al. Alteration in the coding potential and expression of H-ras in human cytomegalovirus–transformed cells. Intervirology. 1994;37:321–9. https://doi.org/10.1159/000150396.
CAS Article PubMed Google Scholar
Shen Y, Zhu H, Shenk T. Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate “hit-and-run” oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc Natl Acad Sci USA. 1997;94:3341–5. https://doi.org/10.1073/pnas.94.7.3341.
CAS Article PubMed PubMed Central Google Scholar
Doniger J, Muralidhar S, Rosenthal LJ. Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate. Clin Microbiol Rev. 1999;12(3):367–82 (PMID: 10398670).
Francis SS, Wallace AD, Wendt GA, et al. In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia. Blood. 2017;129:1680–4. https://doi.org/10.1182/blood-2016-07-723148.
CAS Article PubMed PubMed Central Google Scholar
Wiemels JL, Talbäck M, Francis S, Feychting M. Early infection with cytomegalovirus and risk of childhood hematologic malignancies. Cancer Epidemiol Biomarkers Prev. 2019;28(6):1024–7. https://doi.org/10.1158/1055-9965.EPI-19-0044.
Article PubMed PubMed Central Google Scholar
Éboli LPDCB, Tannuri ACA, Tannuri U. Seropositivity for cytomegalovirus and PCR-EBV monitoring: Protective factors for posttransplant lymphoproliferative disorder in pediatric liver transplant. Pediatr Transplant. 2022;2022:e14226. https://doi.org/10.1111/petr.14226.
Koldehoff M, Lindemann M, Opalka B, et al. Cytomegalovirus induces apoptosis in acute leukemia cells as a virus-versus-leukemia function. Leuk Lymphoma. 2015;56:3189–97. https://doi.org/10.3109/10428194.2015.1032968.
CAS Article PubMed Google Scholar
Oberstein A, Shenk T. Cellular responses to human cytomegalovirus infection: Induction of a mesenchymal-to-epithelial transition (MET) phenotype. Proc Natl Acad Sci USA. 2017;114:E8244–53. https://doi.org/10.1073/pnas.1710799114.
CAS Article PubMed PubMed Central Google Scholar
Yang R, Liang J, Xu GX, et al. Human cytomegalovirus glycoprotein B inhibits migration of breast cancer MDA-MB-231 cells and impairs TGF-β/Smad2/3 expression. Oncol Lett. 2018;15(5):7730–8. https://doi.org/10.3892/ol.2018.8344.
CAS Article PubMed PubMed Central Google Scholar
Erlach KC, Böhm V, Seckert CK, et al. Lymphoma cell apoptosis in the liver induced by distant murine cytomegalovirus infection. J Virol. 2006;80:4801–19. https://doi.org/10.1128/JVI.80.10.4801-4819.2006.
CAS Article PubMed PubMed Central Google Scholar
Erlach KC, Podlech J, Rojan A, Reddehase MJ. Tumor control in a model of bone marrow transplantation and acute liver-infiltrating B-cell lymphoma: an unpredicted novel function of cytomegalovirus. J Virol. 2002;76:2857–70. https://doi.org/10.1128/jvi.76.6.2857-2870.2002.
CAS Article PubMed PubMed Central Google Scholar
Elmaagacli AH, Steckel NK, Koldehoff M, et al. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood. 2011;118:1402–12. https://doi.org/10.1182/blood-2010-08-304121.
CAS Article PubMed Google Scholar
Green ML, Leisenring WM, Xie H, et al. CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Blood. 2013;122:1316–24. https://doi.org/10.1182/blood-2013-02-487074.
CAS Article PubMed PubMed Central Google Scholar
Koldehoff M, Ross SR, Dührsen U, et al. Early CMV-replication after allogeneic stem cell transplantation is associated with a reduced relapse risk in lymphoma. Leuk Lymphoma. 2017;58:822–33. https://doi.org/10.1080/10428194.2016.1217524 (PMID: 27687578).
CAS Article PubMed Google Scholar
Inagaki J, Noguchi M, Kurauchi K, et al. Effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic stem cell transplantation in pediatric acute leukemia. Biol Blood Marrow Transplant. 2016;22:300–6. https://doi.org/10.1016/j.bbmt.2015.09.006.
Litjens NHR, van der Wagen L, Kuball J, Kwekkeboom J. Potential beneficial effects of cytomegalovirus infection after transplantation. Front Immunol. 2018;9:389. https://doi.org/10.3389/fimmu.2018.00389.
CAS Article PubMed PubMed Central Google Scholar
Lilleri D, Gerna G, Furione M, Zavattoni M, Spinillo A. Neutralizing and ELISA IgG antibodies to human cytomegalovirus glycoprotein complexes may help date the onset of primary infection in pregnancy. J Clin Virol. 2016;81:16–24. https://doi.org/10.1016/j.jcv.2016.05.007.
CAS Article PubMed Google Scholar
Theobald SJ, Khailaie S, Meyer-Herman M, Volk V, Olbrich H, Danisch S. Signatures of T and B cell development, functional responses and PD-1 upregulation after HCMV latent infection and reactivations in Nod.Rag.Gamma Mice humanized with cord blood CD34+ cells. Front Immunol. 2018;9:2734. https://doi.org/10.3389/fimmu.2018.02734.
CAS Article PubMed PubMed Central Google Scholar
Martins JP, Andoniou CE, Fleming P, Kuns RD, Schuster IS, Voigt V, et al. Strain-specific antibody therapy prevents cytomegalovirus reactivation after transplantation. Science. 2019;363(6424):288–93. https://doi.org/10.1126/science.aat0066.
CAS Article PubMed Google Scholar
Gerna G, Lilleri D. Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine. New Microbiol. 2019;42(1):1–20 (PMID: 30671581).
Theobald SJ, Kreer C, Khailaie S, Bonifacius A, Eiz-Vesper B, Figueiredo C, et al. Repertoire characterization and validation of gB-specific human IgG3 directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV. PLoS Pathog. 2020;16(7):e1008560. https://doi.org/10.1371/journal.ppat.1008560.
CAS Article PubMed PubMed Central Google Scholar
Fritz A, Percy C, Jack A, et al editors. International classification of diseases for oncology. 3rd ed. Malta: World Health Organization; 2013.
Swerdlow SH, Campo E, Pilleri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organizartion classification of lymphoid neoplasms. Blood. 2016;127:2375–90. https://doi.org/10.1182/blood-2016-01-643569.
留言 (0)